Skip to content

What became of the genetics revolution?

The head of Stanford Medicine on what’s next

Levels <[email protected]>

to the archive

Thursday, August 20, 2026

Levels explores the genetics revolution and its lessons for the next healthcare data revolution, driven by wearables, continuous monitoring, and AI interpretation. Dr. Euan Ashley shares his experience with genomics to preview what's next. He highlights key takeaways, including the potential of AI for empathy at scale.

Read this email as text

What became of the genetics revolution?

What the genetics revolution can teach the next one

Healthcare has already lived through one data revolution: genomics. Sequencing a genome went from a billion-dollar, years-long undertaking to a few hundred dollars and a few hours. But getting the data wasn’t the hard part for long. Making sense of it was. Dr. Euan Ashley, who chairs Stanford's Department of Medicine and led the team that performed the first clinical interpretation of a human genome back in 2009, has spent fifteen years living that gap firsthand. As healthcare heads into its next data revolution—wearables, continuous monitoring, AI interpretation—his experience with the last one is a useful preview of what's about to repeat, and what won't.

See what's next →

Five Key Takeaways

1. AI reproduced a year of research work in about thirty minutes.

Ashley ran his own genome, sequenced back in 2009, through Claude with a short prompt. It matched work that had once taken his team months for about five dollars in computing cost.

2. That speed is built on decades of infrastructure.

The AI relied on databases, tools, and reference standards the genomics community spent years building by hand, an effort that is now scaling with these tools.

Archived for reference and commentary. Levels, its logos and content are the property of their respective owners; Inbox Archive claims no affiliation and has disabled all links. If you own this content and would like it removed, get in touch.